drugset / Trial / NCT02868827

Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.

NCT02868827

Phase 2/3 Terminated 127 enrolled King Abdullah Medical City
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of the research study is to determine whether a single high dose of vitamin D is helpful in reducing critical illness related complications in intensive care patients who are having sever vitamin D deficiency. Vitamin D deficiency is quite common in critically ill patients ranging from 81.5% to 99%. A number of scientific studies have documented a strong correlation between low levels of vit.D and increased rate of adverse outcomes including infection, acute kidney injury and mortality in ICU patients. A recent randomized controlled trial (RCT) has demonstrated a 50% reduction in hospital mortality in severe vit.D deficient patients following a single high dose of cholecalciferol (Vitamin D3). However, the role of Vit.D supplementation to boost up host immune system and eventually reduction of mortality has yet to be determined by large randomized controlled trials in humans. Hence the study aims to run a randomized controlled trial (RCT) in order to study the role of Vitamin D in critically ill patients.

Timeline

Start
2017-08-27
Primary completion
2019-11-09
Completion
2019-11-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 400000 iu Other

Indications